# PT Nusantara Genetika Semesta

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pt-nusantara-genetika-semesta

- Industry: Biotechnology
- Headquarters: Jakarta, Indonesia
- Website: www.nusantics.com
- Total disclosed funding: $2.3M
- Latest round: Series A (Feb 4, 2021)
- Investors on record: 2

## About

PT Nusantara Genetika Semesta is a precision molecular diagnostics company focused on developing innovative healthcare and agricultural solutions, enhancing disease detection and crop efficiency.Founded in 2019 in Jakarta, Indonesia, PT Nusantara Genetika Semesta specializes in molecular diagnostics and agricultural innovations. The company has secured USD 500,000 in funding from East Ventures as part of their latest investment round in November 2023, contributing to a total of USD 500,000 raised. Revata Utama, Sharlini Putri, and Vincent Kurniawan are the founders, with Revata Utama serving as the CEO. The firm has completed three funding deals.Nusantics develops the PathoScan hrHPV qPCR Kit for non-invasive screening of high-risk human papillomaviruses, aiming to improve early cervical cancer detection. Additionally, the CeKolam product enhances shrimp production for Indonesian farmers by addressing prevalent challenges such as disease management and yield optimization. Their primary clientele includes healthcare providers, shrimp farmers, and laboratories across Southeast Asia, with a focus on operational efficiency and health outcomes.Nusantics generates revenue through direct sales of its molecular diagnostic products and agricultural solutions, mainly via B2B channels with laboratories and healthcare institutions. Their pricing model encompasses individual product sales and comprehensive shrimp farming solutions, which may involve service agreements or partnerships. The firm is positioned to achieve profitability by 2025 through structured customer engagement and retention strategies.In November 2023, PT Nusantara Genetika Semesta raised USD 500,000 in venture funding to support upcoming product launches and market expansions. The company plans to introduce new diagnostics and agricultural products while targeting expansion into additional Southeast Asian markets by 2025. The recent funding will facilitate the development of these initiatives and strengthen their market presence.

## Funding rounds

- Series A, Feb 4, 2021, $1.5M — East Ventures
- Seed, Mar 17, 2020, $0.8M — East Ventures, Samora Group Indonesia

## Investors

- East Ventures (https://capitalatlas.ai/funds/east-ventures) — Seed, Series A
- Samora Group Indonesia — Seed